Showing results (61-70 of 7,567) with videos related to

Sort By:
Pageof 757
Statistics in Medicine|July 18, 2019
Assessing pharmacokinetic marker correlates of outcome, with application to antibody prevention efficacy trialsPeter B Gilbert, Yuanyuan Zhang, Erika Rudnicki, et al.
Journal of the American Statistical Association|November 5, 2013
Sensitivity Analysis of Per-Protocol Time-to-Event Treatment Efficacy in Randomized Clinical TrialsPeter B Gilbert, Bryan E Shepherd, Michael G Hudgens
Lifetime Data Analysis|April 11, 2020
Analysis of the time-varying Cox model for the cause-specific hazard functions with missing causesFei Heng, Yanqing Sun, Seunggeun Hyun, et al.
Statistics in Medicine|October 30, 2014
Comparing and combining biomarkers as principal surrogates for time-to-event clinical endpointsErin E Gabriel, Michael C Sachs, Peter B Gilbert
Biometrical Journal. Biometrische Zeitschrift|March 1, 2018
Hypothesis tests for stratified mark-specific proportional hazards models with missing covariates, with application to HIV vaccine efficacy trialsYanqing Sun, Li Qi, Guangren Yang, et al.
Plos Computational Biology|June 23, 2006
On modeling HIV and T cells in vivo: assessing causal estimators in vaccine trialsW David Wick, Peter B Gilbert, Steven G Self
Journal of the Royal Statistical Society. Series C, Applied Statistics|November 16, 2020
A Hybrid Approach for the Stratified Mark-Specific Proportional Hazards Model with Missing Covariates and Missing Marks, with Application to Vaccine Efficacy TrialsYanqing Sun, Li Qi, Fei Heng, et al.
Journal of the American Statistical Association|August 26, 2024
Inference for treatment-specific survival curves using machine learningTed Westling, Alex Luedtke, Peter B Gilbert, et al.
Pageof 757